GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Anymedi Inc (XKRX:390110) » Definitions » COGS-to-Revenue

Anymedi (XKRX:390110) COGS-to-Revenue : 0.59 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Anymedi COGS-to-Revenue?

Anymedi's Cost of Goods Sold for the six months ended in Dec. 2024 was ₩806 Mil. Its Revenue for the six months ended in Dec. 2024 was ₩1,360 Mil.

Anymedi's COGS to Revenue for the six months ended in Dec. 2024 was 0.59.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Anymedi's Gross Margin % for the six months ended in Dec. 2024 was 40.71%.

Anymedi COGS-to-Revenue Historical Data

The historical data trend for Anymedi's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anymedi COGS-to-Revenue Chart

Anymedi Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue
1.88 1.87 1.60 0.82 0.59

Anymedi Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
COGS-to-Revenue 1.88 1.87 1.60 0.82 0.59

Anymedi COGS-to-Revenue Calculation

Anymedi's COGS to Revenue for the fiscal year that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=806.064 / 1359.547
=0.59

Anymedi's COGS to Revenue for the quarter that ended in Dec. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=806.064 / 1359.547
=0.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Anymedi  (XKRX:390110) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Anymedi's Gross Margin % for the six months ended in Dec. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 806.064 / 1359.547
=40.71 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Anymedi COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Anymedi's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Anymedi Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Anymedi Inc (XKRX:390110) » Definitions » COGS-to-Revenue
Comparable Companies
VEEV GEHC ASX:PME TEM DOCS TSE:2413 HQY WAY BTSG HKSE:02587 HNGE NSE:IKS SZSE:300253 PRVA HKSE:02228 NSE:SAGILITY PINC HKSE:01833 CERT HKSE:02506
Traded in Other Exchanges
N/A
Address
4-ho, 137, Olympic-ro 35-gil, 12th Floor, Songpa-gu, Seoul, KOR, 05510
Website
https://www.anymedi.com
Anymedi Inc provides patient-specific medical solutions required for surgical procedures. It offers surgical solutions for defects, disorders, and diseases based on medical image data. Patient-specific 3D-printed simulators, surgical guides, and implants.

Anymedi Headlines

No Headlines